Anti-Mouse MHC Class I (H-2Kd, H-2Dd) [Clone 34-1-2S] — Purified in vivo GOLD™ Functional Grade
Anti-Mouse MHC Class I (H-2Kd, H-2Dd) [Clone 34-1-2S] — Purified in vivo GOLD™ Functional Grade
Product No.: H691
Clone 34-1-2S Target MHC Class I (H-2Kd, H-2Dd) Formats AvailableView All Product Type Hybridoma Monoclonal Antibody Alternate Names H-2Kd: H-2 class I histocompatibility antigen, K-D alpha chain H-2Dd: H-2 class I histocompatibility antigen, D-D alpha chain Isotype Mouse IgG2a k Applications ELISA , FA , FC |
Antibody DetailsProduct DetailsReactive Species Mouse Host Species Mouse Recommended Dilution Buffer Immunogen Spleen cells from (B6 X DBA/2) BDF1 mice Product Concentration ≥ 5.0 mg/ml Endotoxin Level < 1.0 EU/mg as determined by the LAL method Purity ≥95% monomer by analytical SEC ⋅ >95% by SDS Page Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. State of Matter Liquid Product Preparation The In Vivo GOLD™ Advantage: Built for Confounding-Free Research When performing functional in vivo assays, the purity of your reagent is just as critical as its specificity. Contaminants like endotoxins can inadvertently activate immune cells, triggering non-specific inflammatory responses that compromise your data. Leinco’s In Vivo GOLD™ Functional Grade formulation sets the industry benchmark for preclinical research. While standard commercial alternatives allow higher endotoxin thresholds, Clone 34-1-2S In Vivo GOLD™ guarantees: 1.) Ultra-Low Endotoxin Levels: Strictly verified to be< 1.0 EU/mg}, but often reaching < 0.5 EU/mg, drastically minimizing artifactual cell activation. 2.) High Monomeric Purity: Superb purity as determined by SDS-PAGE and analytical size-exclusion chromatography (SEC), ensuring maximum functional binding efficiency. 3.) Aseptic Packaging: Formulated in phosphate-buffered saline (PBS) without any carrier proteins, stabilizers, potassium, calcium, or preservatives (like sodium azide) that could alter cellular physiology or toxicologically impact live animal models. 4.) Manufactured in USA (St. Louis Missouri): Our Functional grade preclinical antibodies are manufactured in an animal free facility using only in vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage and Handling Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles. Regulatory Status Research Use Only Country of Origin USA Shipping 2 – 8° C Wet Ice Additional Applications Reported In Literature ? Validated Applications for Clone 34-1-2S Manufactured using advanced in vitro cell culture techniques in an animal-free facility, this monoclonal antibody is optimized for high-performance functionality. It is widely leveraged in peer-reviewed literature for: - In Vivo & In Vitro Functional Assays: Blocking or modulating MHC Class I-mediated antigen presentation or T-cell activation. - Complement-Dependent Cytotoxicity (CDC): Investigating antibody-mediated cytotoxicity and complement pathway mechanics. - Flow Cytometry (FCM) & Immunophenotyping: Direct cell-surface staining and haplotype screening. Immunohistochemistry (IHC) & Immunoprecipitation (IP): Identifying MHC Class I tissue distribution and protein complex isolation. Literature Validated Applications for Clone 34-1-2S Manufactured using advanced in vitro cell culture techniques in an animal-free facility, this monoclonal antibody is optimized for high-performance functionality. It is widely leveraged in peer-reviewed literature for: - In Vivo & In Vitro Functional Assays: Blocking or modulating MHC Class I-mediated antigen presentation or T-cell activation. - Complement-Dependent Cytotoxicity (CDC): Investigating antibody-mediated cytotoxicity and complement pathway mechanics. - Flow Cytometry (FCM) & Immunophenotyping: Direct cell-surface staining and haplotype screening. - Immunohistochemistry (IHC) & Immunoprecipitation (IP): Identifying MHC Class I tissue distribution and protein complex isolation. - Immunoaffinity purification (IP): Clone 34-1-2S is a foundational reagent in immunopeptidomics and neoantigen discovery mapping. Researchers profiling the tumor immunopeptidome leverage Clone 34-1-2S for the immunoaffinity purification (IP) of intact MHC Class I-peptide complexes from murine cell lines and tissues. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity 34-1-2S activity is directed against H-2Dd and H-2Kd MHC Class I antigens. 34-1-2S
cross-reacts with Kb, s, r, q, and p. Binding to H-2Kb is weak. 34-1-2S does not cross-react with
H-2k and H-2f. Background Anti-Mouse MHC Class I (H-2Kᵈ / H-2Dᵈ) Antibody (Clone 34-1-2S); Understanding the Target: MHC Class I H-2Kᵈ and H-2Dᵈ HaplotypesMajor Histocompatibility Complex (MHC) Class I molecules are heterodimeric surface glycoproteins consisting of a polymorphic alpha heavy chain non-covalently associated with β2-microglobulin. Expressed on virtually all nucleated cells, MHC Class I molecules play a fundamental role in the adaptive immune system by presenting endogenously synthesized antigenic peptides to cytotoxic CD8 positive T cells. Clone 34-1-2S specifically targets the H-2Kᵈ and H-2Dᵈ MHC Class I alloantigens. This makes it an indispensable tool for researchers working with specific murine strains—such as BALB/c or DBA/2—that carry the "d" haplotype. Additionally, Clone 34-1-2S is documented to exhibit cross-reactivity with MHC Class I alloantigens of the b, s, r, q, or p haplotypes, offering broad experimental utility across diverse mouse models. Antigen Distribution H-2Kd and Dd are present on all nucleated cells. Ligand/Receptor Peptides derived from normal protein catabolism or foreign proteins e.g., viral infection, allotransplantation Research Area Immunology . Immunity . MHC Class I . TRALI Leinco Antibody AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. Clone 34-1-2S is most commonly applied in vivo in mice for the functional blockade and depletion of MHC class I molecules (H-2Kd, H-2Dd), manipulation of antigen presentation to CD8+ T cells, and experimental studies of immune responses involving cytotoxic T lymphocytes. Key in vivo applications include:
These applications exploit the specificity of 34-1-2S for a common epitope in the α3 domain of H-2Kd and H-2Dd, enabling the selective targeting of these mouse MHC class I haplotypes in vivo. Dosage and administration routes are determined empirically for specific experimental goals and require careful titration to avoid off-target effects. The most commonly used antibodies or proteins in combination with 34-1-2S (which targets mouse MHC Class I, specifically H-2Kd and H-2Dd) in the literature are those involved in immune cell characterization and antigen presentation studies. While specific pairings vary by experiment, several commonly co-used antibodies and proteins include:
These antibodies and proteins are typically used in applications such as:
In summary, the most commonly paired antibodies/proteins with 34-1-2S are those targeting CD8, CD3/TCR, other MHC Class I molecules (like H-2Kb), lineage markers (CD45, CD4, CD19), β2 microglobulin, and isotype controls, depending on the experimental context. Clone 34-1-2S is a widely cited monoclonal antibody used for identifying and studying mouse MHC class I antigens, specifically H-2K(^d) and H-2D(^d), with notable applications and biological findings in immunology and transplantation research. Key findings from its scientific literature citations include:
Summary Table: Key Attributes of 34-1-2S in Literature
These findings highlight 34-1-2S as a foundational tool for mouse MHC class I research, with ongoing impact demonstrated in both basic and translational immunology. The dosing regimens for the 34-1-2S monoclonal antibody, which targets MHC Class I H-2Kd and H-2Dd in mice, primarily depend on the application rather than the mouse model itself. This antibody is commonly used in flow cytometric analysis to study the expression of MHC class I antigens on nucleated cells from mice of the H-2Kd/H-2Dd haplotype. General Guidelines for Use:
Variation Considerations:While there is no detailed information on varying dosing regimens across different mouse models for clone 34-1-2S specifically, dosing strategies in immunological research often depend on the experimental goals (e.g., depletion of specific cell subsets, modulation of immune responses). However, for most applications involving this antibody, the dosage is standardized for flow cytometry rather than being tailored to specific mouse models. References & Citations1 Yoshida R. Adv Immunol. 124:207-247. 2014. 2 Ozato K, Mayer NM, Sachs DH. Transplantation. 34(3):113-120. 1982. 3 Zeeuw van der Laan EAN, van der Velden S, Bentlage AEH, et al. Blood Adv. 4(16):3875-3885. 2020. 4 Looney MR, Su X, Van Ziffle JA, et al. J Clin Invest. 116(6):1615-1623. 2006. 5 Looney MR, Nguyen JX, Hu Y, et al. J Clin Invest. Nov;119(11):3450-3461. 2009. 6 Strait RT, Hicks W, Barasa N, et al. J Exp Med. 208(12):2525-2544. 2011. 7 van der Velden S, van Osch TLJ, Seghier A, et al. Blood. 143(1):79-91. 2024. Technical ProtocolsCertificate of Analysis |
Formats Available
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
